Form 4: Twist Bioscience COO Patrick John Finn Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4


Patrick John Finn, COO of Twist Bioscience, sold 6,239 shares of common stock on November 6, 2024, to cover tax obligations related to vesting Performance Stock Units.

Summary

  • On November 6, 2024, Patrick John Finn, the President and COO of Twist Bioscience Corp, sold 6,239 shares of the company's common stock.
  • The sale was executed at a price of $44.605 per share.
  • The transaction was conducted to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain Performance Stock Units (PSUs).
  • Following the transaction, Finn directly owns 231,401 shares of Twist Bioscience Corp.
  • The tax withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations, which is a common practice.

Industry Context

Insider sales are a common occurrence, especially to cover tax obligations related to equity compensation. The market typically views these sales in the context of the executive's overall holdings and the company's performance.

Stakeholder Impact

  • The sale may have a minor impact on shareholders due to the small volume of shares sold.

Key Dates

DateDescription
11/06/2024Date of transaction: Sale of 6,239 shares of Twist Bioscience common stock.
11/08/2024Date of signature by Attorney-in-Fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.